https://stock.noler.com/us/stock/orchard-therapeutics-plc https://stock.noler.com/us/stock/orchard-therapeutics-plc/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/orchard-therapeutics-plc/accounts-payable https://stock.noler.com/us/stock/orchard-therapeutics-plc/accounts-receivable https://stock.noler.com/us/stock/orchard-therapeutics-plc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/orchard-therapeutics-plc/accrued-income-taxes https://stock.noler.com/us/stock/orchard-therapeutics-plc/accrued-professional-fees-current https://stock.noler.com/us/stock/orchard-therapeutics-plc/accumulated-depreciation https://stock.noler.com/us/stock/orchard-therapeutics-plc/additional-paid-in-capital https://stock.noler.com/us/stock/orchard-therapeutics-plc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/orchard-therapeutics-plc/amortization https://stock.noler.com/us/stock/orchard-therapeutics-plc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/orchard-therapeutics-plc/aoci https://stock.noler.com/us/stock/orchard-therapeutics-plc/asset-impairment-charges https://stock.noler.com/us/stock/orchard-therapeutics-plc/assets-fair-value-disclosure https://stock.noler.com/us/stock/orchard-therapeutics-plc/assets-noncurrent https://stock.noler.com/us/stock/orchard-therapeutics-plc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/orchard-therapeutics-plc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/orchard-therapeutics-plc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/orchard-therapeutics-plc/available-for-sale-debt-maturities-remainder-of-fiscal-year-amortized-cost-basis https://stock.noler.com/us/stock/orchard-therapeutics-plc/available-for-sale-debt-maturities-single-maturity-date-amortized-cost-basis https://stock.noler.com/us/stock/orchard-therapeutics-plc/available-for-sale-debt-maturities-within-one-year-amortized-cost https://stock.noler.com/us/stock/orchard-therapeutics-plc/available-for-sale-debt-securities https://stock.noler.com/us/stock/orchard-therapeutics-plc/basic-shares https://stock.noler.com/us/stock/orchard-therapeutics-plc/capital-expenditures https://stock.noler.com/us/stock/orchard-therapeutics-plc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/orchard-therapeutics-plc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/orchard-therapeutics-plc/cash-and-equivalents https://stock.noler.com/us/stock/orchard-therapeutics-plc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/orchard-therapeutics-plc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/orchard-therapeutics-plc/cash-collateral-for-borrowed-securities https://stock.noler.com/us/stock/orchard-therapeutics-plc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/orchard-therapeutics-plc/cash-flow-breakdown https://stock.noler.com/us/stock/orchard-therapeutics-plc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/orchard-therapeutics-plc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/orchard-therapeutics-plc/common-stock-value https://stock.noler.com/us/stock/orchard-therapeutics-plc/comprehensive-income https://stock.noler.com/us/stock/orchard-therapeutics-plc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/orchard-therapeutics-plc/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/orchard-therapeutics-plc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/orchard-therapeutics-plc/cost-of-revenue https://stock.noler.com/us/stock/orchard-therapeutics-plc/costs-and-expenses https://stock.noler.com/us/stock/orchard-therapeutics-plc/cover-page-shares-outstanding https://stock.noler.com/us/stock/orchard-therapeutics-plc/cumulative-effect-of-new-accounting-principle-in-period-of-adoption https://stock.noler.com/us/stock/orchard-therapeutics-plc/current-assets https://stock.noler.com/us/stock/orchard-therapeutics-plc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/orchard-therapeutics-plc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/orchard-therapeutics-plc/current-liabilities https://stock.noler.com/us/stock/orchard-therapeutics-plc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/orchard-therapeutics-plc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/orchard-therapeutics-plc/debt-carrying-amount https://stock.noler.com/us/stock/orchard-therapeutics-plc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/orchard-therapeutics-plc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/orchard-therapeutics-plc/debt-maturing-after-year-five https://stock.noler.com/us/stock/orchard-therapeutics-plc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/orchard-therapeutics-plc/debt-maturing-in-year-five https://stock.noler.com/us/stock/orchard-therapeutics-plc/debt-maturing-in-year-four https://stock.noler.com/us/stock/orchard-therapeutics-plc/debt-maturing-in-year-three https://stock.noler.com/us/stock/orchard-therapeutics-plc/debt-maturing-in-year-two https://stock.noler.com/us/stock/orchard-therapeutics-plc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-other-tax-expense-benefit https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-revenue https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-tax-assets-gross https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-tax-assets-net https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-tax-assets-other https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/orchard-therapeutics-plc/deferred-tax-liabilities https://stock.noler.com/us/stock/orchard-therapeutics-plc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/orchard-therapeutics-plc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/orchard-therapeutics-plc/deposits-assets-noncurrent https://stock.noler.com/us/stock/orchard-therapeutics-plc/depreciation https://stock.noler.com/us/stock/orchard-therapeutics-plc/depreciation-and-amortization https://stock.noler.com/us/stock/orchard-therapeutics-plc/diluted-shares https://stock.noler.com/us/stock/orchard-therapeutics-plc/dividends-common-stock https://stock.noler.com/us/stock/orchard-therapeutics-plc/dividends-common-stock-cash https://stock.noler.com/us/stock/orchard-therapeutics-plc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/orchard-therapeutics-plc/employee-related-liabilities-current https://stock.noler.com/us/stock/orchard-therapeutics-plc/eps https://stock.noler.com/us/stock/orchard-therapeutics-plc/eps-basic https://stock.noler.com/us/stock/orchard-therapeutics-plc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/orchard-therapeutics-plc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/orchard-therapeutics-plc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/orchard-therapeutics-plc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/orchard-therapeutics-plc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/orchard-therapeutics-plc/financing-cash-flow https://stock.noler.com/us/stock/orchard-therapeutics-plc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/orchard-therapeutics-plc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/orchard-therapeutics-plc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/orchard-therapeutics-plc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/orchard-therapeutics-plc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/orchard-therapeutics-plc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/orchard-therapeutics-plc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/orchard-therapeutics-plc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/orchard-therapeutics-plc/finite-lived-intangible-assets-foreign-currency-translation-gain-loss https://stock.noler.com/us/stock/orchard-therapeutics-plc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/orchard-therapeutics-plc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/orchard-therapeutics-plc/finite-lived-license-agreements-gross https://stock.noler.com/us/stock/orchard-therapeutics-plc/foreign-currency-exchange-rate-translation https://stock.noler.com/us/stock/orchard-therapeutics-plc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/orchard-therapeutics-plc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/orchard-therapeutics-plc/foreign-pretax-income https://stock.noler.com/us/stock/orchard-therapeutics-plc/form-d-other https://stock.noler.com/us/stock/orchard-therapeutics-plc/form-d-stocks https://stock.noler.com/us/stock/orchard-therapeutics-plc/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/orchard-therapeutics-plc/income-loss-from https://stock.noler.com/us/stock/orchard-therapeutics-plc/income-tax https://stock.noler.com/us/stock/orchard-therapeutics-plc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/orchard-therapeutics-plc/income-taxes-paid https://stock.noler.com/us/stock/orchard-therapeutics-plc/increase-decrease-in-accounts-and-other-receivables https://stock.noler.com/us/stock/orchard-therapeutics-plc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/orchard-therapeutics-plc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/orchard-therapeutics-plc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/orchard-therapeutics-plc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/orchard-therapeutics-plc/increase-decrease-in-income-taxes-receivable https://stock.noler.com/us/stock/orchard-therapeutics-plc/increase-decrease-in-inventories https://stock.noler.com/us/stock/orchard-therapeutics-plc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/orchard-therapeutics-plc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/orchard-therapeutics-plc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/orchard-therapeutics-plc/insider-transactions-other https://stock.noler.com/us/stock/orchard-therapeutics-plc/insider-transactions-other/purchases https://stock.noler.com/us/stock/orchard-therapeutics-plc/insider-transactions-stock-options https://stock.noler.com/us/stock/orchard-therapeutics-plc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/orchard-therapeutics-plc/interest-expense https://stock.noler.com/us/stock/orchard-therapeutics-plc/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/orchard-therapeutics-plc/interest-paid-net https://stock.noler.com/us/stock/orchard-therapeutics-plc/inventory https://stock.noler.com/us/stock/orchard-therapeutics-plc/inventory-raw-materials https://stock.noler.com/us/stock/orchard-therapeutics-plc/inventory-work-in-process https://stock.noler.com/us/stock/orchard-therapeutics-plc/investing-cash-flow https://stock.noler.com/us/stock/orchard-therapeutics-plc/investment-income-interest https://stock.noler.com/us/stock/orchard-therapeutics-plc/lease-cost https://stock.noler.com/us/stock/orchard-therapeutics-plc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/orchard-therapeutics-plc/lessor-operating-lease-payments-to-be-received https://stock.noler.com/us/stock/orchard-therapeutics-plc/lessor-operating-lease-payments-to-be-received-five-years https://stock.noler.com/us/stock/orchard-therapeutics-plc/lessor-operating-lease-payments-to-be-received-four-years https://stock.noler.com/us/stock/orchard-therapeutics-plc/lessor-operating-lease-payments-to-be-received-next-twelve-months https://stock.noler.com/us/stock/orchard-therapeutics-plc/lessor-operating-lease-payments-to-be-received-thereafter https://stock.noler.com/us/stock/orchard-therapeutics-plc/lessor-operating-lease-payments-to-be-received-three-years https://stock.noler.com/us/stock/orchard-therapeutics-plc/lessor-operating-lease-payments-to-be-received-two-years https://stock.noler.com/us/stock/orchard-therapeutics-plc/letters-of-credit-outstanding-amount https://stock.noler.com/us/stock/orchard-therapeutics-plc/level-3-liability-purchases https://stock.noler.com/us/stock/orchard-therapeutics-plc/level-3-liability-settlements https://stock.noler.com/us/stock/orchard-therapeutics-plc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/orchard-therapeutics-plc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/orchard-therapeutics-plc/line-of-credit-facility-periodic-payment-interest https://stock.noler.com/us/stock/orchard-therapeutics-plc/line-of-credit-facility-remaining-borrowing-capacity https://stock.noler.com/us/stock/orchard-therapeutics-plc/long-term-debt https://stock.noler.com/us/stock/orchard-therapeutics-plc/long-term-notes-payable https://stock.noler.com/us/stock/orchard-therapeutics-plc/marketable-securities https://stock.noler.com/us/stock/orchard-therapeutics-plc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/orchard-therapeutics-plc/net-change-in-cash https://stock.noler.com/us/stock/orchard-therapeutics-plc/net-income https://stock.noler.com/us/stock/orchard-therapeutics-plc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/orchard-therapeutics-plc/nontrade-receivables-current https://stock.noler.com/us/stock/orchard-therapeutics-plc/notes-payable-current https://stock.noler.com/us/stock/orchard-therapeutics-plc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/orchard-therapeutics-plc/oci-net-of-tax https://stock.noler.com/us/stock/orchard-therapeutics-plc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-cash-flow https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-income https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-assets https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-impairment-loss https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-liability https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-liability-current https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-payments https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-payments-due https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-payments-due-current https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/orchard-therapeutics-plc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/orchard-therapeutics-plc/other-accrued-liabilities-current https://stock.noler.com/us/stock/orchard-therapeutics-plc/other-income https://stock.noler.com/us/stock/orchard-therapeutics-plc/other-noncash-income-expense https://stock.noler.com/us/stock/orchard-therapeutics-plc/other-noncurrent-assets https://stock.noler.com/us/stock/orchard-therapeutics-plc/other-noncurrent-liabilities https://stock.noler.com/us/stock/orchard-therapeutics-plc/other-nonoperating-income-expense https://stock.noler.com/us/stock/orchard-therapeutics-plc/other-prepaid-expense-current https://stock.noler.com/us/stock/orchard-therapeutics-plc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/orchard-therapeutics-plc/payments-for-restructuring https://stock.noler.com/us/stock/orchard-therapeutics-plc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/orchard-therapeutics-plc/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/orchard-therapeutics-plc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/orchard-therapeutics-plc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/orchard-therapeutics-plc/payments-to-acquire-restricted-certificates-of-deposit https://stock.noler.com/us/stock/orchard-therapeutics-plc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/orchard-therapeutics-plc/pretax-income https://stock.noler.com/us/stock/orchard-therapeutics-plc/pretax-income-domestic https://stock.noler.com/us/stock/orchard-therapeutics-plc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/orchard-therapeutics-plc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/orchard-therapeutics-plc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/orchard-therapeutics-plc/proceeds-from-issuance-of-redeemable-convertible-preferred-stock https://stock.noler.com/us/stock/orchard-therapeutics-plc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/orchard-therapeutics-plc/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/orchard-therapeutics-plc/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/orchard-therapeutics-plc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/orchard-therapeutics-plc/proceeds-from-stock-issued https://stock.noler.com/us/stock/orchard-therapeutics-plc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/orchard-therapeutics-plc/proceeds-from-stock-plans https://stock.noler.com/us/stock/orchard-therapeutics-plc/profit-loss https://stock.noler.com/us/stock/orchard-therapeutics-plc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/orchard-therapeutics-plc/property-plant-equipment https://stock.noler.com/us/stock/orchard-therapeutics-plc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/orchard-therapeutics-plc/provision-for-loss-on-contracts https://stock.noler.com/us/stock/orchard-therapeutics-plc/public-float https://stock.noler.com/us/stock/orchard-therapeutics-plc/realized-gains-on-securities https://stock.noler.com/us/stock/orchard-therapeutics-plc/repayments-of-lines-of-credit https://stock.noler.com/us/stock/orchard-therapeutics-plc/repayments-of-notes-payable https://stock.noler.com/us/stock/orchard-therapeutics-plc/research-and-development https://stock.noler.com/us/stock/orchard-therapeutics-plc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/orchard-therapeutics-plc/restricted-stock-value-shares-issued-net-of-tax-withholdings https://stock.noler.com/us/stock/orchard-therapeutics-plc/restructuring-charges https://stock.noler.com/us/stock/orchard-therapeutics-plc/restructuring-reserve https://stock.noler.com/us/stock/orchard-therapeutics-plc/restructuring-reserve-translation-and-other-adjustment https://stock.noler.com/us/stock/orchard-therapeutics-plc/retained-earnings https://stock.noler.com/us/stock/orchard-therapeutics-plc/revenue https://stock.noler.com/us/stock/orchard-therapeutics-plc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/orchard-therapeutics-plc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/orchard-therapeutics-plc/sga-expense https://stock.noler.com/us/stock/orchard-therapeutics-plc/shareholders-equity https://stock.noler.com/us/stock/orchard-therapeutics-plc/shares-issued https://stock.noler.com/us/stock/orchard-therapeutics-plc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-award-per-share-weighted-average-price-of-shares-purchased https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-award-rsu-forfeitures-grant-date-fair-value https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-based-compensation https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-compensation-unrecognized-cost-share-based-awards-other-than-options https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-options-exercisable-number https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-options-outstanding-number https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/orchard-therapeutics-plc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/orchard-therapeutics-plc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/orchard-therapeutics-plc/sublease-income https://stock.noler.com/us/stock/orchard-therapeutics-plc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/orchard-therapeutics-plc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/orchard-therapeutics-plc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/orchard-therapeutics-plc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/orchard-therapeutics-plc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/orchard-therapeutics-plc/tax-reconciliation-tax-credits https://stock.noler.com/us/stock/orchard-therapeutics-plc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/orchard-therapeutics-plc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/orchard-therapeutics-plc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/orchard-therapeutics-plc/temporary-equity-shares-issued https://stock.noler.com/us/stock/orchard-therapeutics-plc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/orchard-therapeutics-plc/total-assets https://stock.noler.com/us/stock/orchard-therapeutics-plc/total-liabilities https://stock.noler.com/us/stock/orchard-therapeutics-plc/total-liabilities-and-equity https://stock.noler.com/us/stock/orchard-therapeutics-plc/total-long-term-debt https://stock.noler.com/us/stock/orchard-therapeutics-plc/unamortized-debt-issuance-expense https://stock.noler.com/us/stock/orchard-therapeutics-plc/unrecognized-tax-benefits https://stock.noler.com/us/stock/orchard-therapeutics-plc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/orchard-therapeutics-plc/valuation-allowances-and-reserves-balance https://stock.noler.com/us/stock/orchard-therapeutics-plc/valuation-allowances-and-reserves-change https://stock.noler.com/us/stock/orchard-therapeutics-plc/valuation-allowances-and-reserves-charged-to-cost-and-expense https://stock.noler.com/us/stock/orchard-therapeutics-plc/valuation-allowances-and-reserves-deductions https://stock.noler.com/us/stock/orchard-therapeutics-plc/value-added-tax-receivable-current https://stock.noler.com/us/stock/orchard-therapeutics-plc/variable-lease-cost https://stock.noler.com/us/stock/orchard-therapeutics-plc/weighted-average-number-of-share-outstanding-basic-and-diluted